| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |